Axios @axios
The FDA's approval of Alzheimer's treatment Aduhelm puts physicians in a difficult position: Desperate patients and families may not know or care about the lack of evidence and will want the prescription anyway. https://t.co/64UZTlxJZu — PolitiTweet.org
